Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_0195 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_0195 |
| Peptide Name | gH625 |
| PEPTIDE SEQUENCE (1-letter) | HGLASTLTRWAHYNALIRAFGGG |
| PEPTIDE SEQUENCE (3-letter) | HisGlyLeuAlaSerThrLeuThrArgTrpAlaHisTyrAsnAlaLeuIleArgAlaPheGlyGlyGly |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | Chemically synthesized |
| Peptide Length | 23 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | NA |
| SMILES | NA |
| Cell Line | Human neuroblastoma cell line SH-SY5Y |
| In vitro CONCENTRATION | 5*10^4 cells/well |
| In vitro METHOD | Spectorcluorometric analysis |
| In vitro RESULT | 80% fluoroscence measured at 1 micromolar peptide concentration |
| ANIMAL MODEL | NA |
| In vivo CONCENTRATION | NA |
| In vivo MODE OF DELIVERY | NA |
| In vivo METHOD | NA |
| In vivo RESULT | NA |
| ACTION | NA |
| TRANSPORT TYPE | Transcytosis |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | NA |
| PHYSICAL CONDITION | NA |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 25792823 |